Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Asia Pacific Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service (Assays & Kits, Instruments & Analyzers and Software & Services), By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030

Published Date : 30-Jun-2023

Pages: 128

Formats: PDF

The Asia Pacific Point of Care Molecular Diagnostics Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).

The market is seeing significant growth in a major trend called technological innovation. Major players in the point-of-care molecular diagnostics market are concentrating on offering cutting-edge technology solutions to improve their market position. These businesses are adopting next-generation point-of-care molecular diagnostics technologies and related services, including DNA microarrays, spectral karyotyping imaging, mass spectrometry, enzyme-linked immunosorbent assay (ELISA), PCR, and ELISA, as well as in situ hybridizations, spectral karyotyping imaging, ELISA, and ELISA.

For instance, the molecular point-of-care test for detecting novel COVID-19 (COVID-19) was introduced by Abbott Laboratories, a US-based manufacturer of medical devices, in March 2020. According to the manufacturer, the gadget displays positive findings in five minutes and negative results in thirteen. The ID NOWTM platform, which uses isothermal nucleic acid amplification technology to provide molecular results in a matter of seconds, will be used for this test.

China and Japan are two of the most afflicted Asian nations, and it is projected that Japan's elderly population will rise significantly. More than 20% of the nation's population is over 65. A diversified, heavily populated area with 4.2 billion people, Southern, Eastern, and South-Eastern Asia accounts for 55% of the world's population. As a result, the demand in Asia Pacific is anticipated to increase as a result of the growth in cancer cases, the dearth of sophisticated central laboratory testing facilities, the need for clinical testing among a wider population, and the possibility for PoC molecular assays to be implemented at a reasonable cost.

The China market dominated the Asia Pacific Point of Care Molecular Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $299.2 million by 2030. The Japan market is anticipated grow at a CAGR of 10% during (2023 - 2030). Additionally, The India market would witness a CAGR of 11.4% during (2023 - 2030).

Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others.Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Point of Care Molecular Diagnostics Market is Projected to reach USD 4.1 Billion by 2030, at a CAGR of 10.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Product & Service

  • Assays & Kits
  • Instruments & Analyzers
  • Software & Services Surveillance & Monitoring

By End User

  • Physicians Offices
  • Hospitals & ICUs
  • Research Institutes
  • Others

By Technology

  • RT-PCR
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

By Application

  • Respiratory Diseases
  • Hospital-acquired Infections
  • Sexually Transmitted Diseases
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Bayer AG
  • F.Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Nova Biomedical Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 Asia Pacific Point of Care Molecular Diagnostics Market, by End User
1.4.3 Asia Pacific Point of Care Molecular Diagnostics Market, by Technology
1.4.4 Asia Pacific Point of Care Molecular Diagnostics Market, by Application
1.4.5 Asia Pacific Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
4.1 Asia Pacific Assays & Kits Market by Country
4.2 Asia Pacific Instruments & Analyzers Market by Country
4.3 Asia Pacific Software & Services Market by Country

Chapter 5. Asia Pacific Point of Care Molecular Diagnostics Market by End User
5.1 Asia Pacific Physicians Offices Market by Country
5.2 Asia Pacific Hospitals & ICUs Market by Country
5.3 Asia Pacific Research Institutes Market by Country
5.4 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Point of Care Molecular Diagnostics Market by Technology
6.1 Asia Pacific RT-PCR Market by Country
6.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Point of Care Molecular Diagnostics Market by Application
7.1 Asia Pacific Respiratory Diseases Market by Country
7.2 Asia Pacific Hospital-acquired Infections Market by Country
7.3 Asia Pacific Sexually Transmitted Diseases Market by Country
7.4 Asia Pacific Cancer Market by Country
7.5 Asia Pacific Hepatitis Market by Country
7.6 Asia Pacific Gastrointestinal Disorders Market by Country
7.7 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Point of Care Molecular Diagnostics Market by Country
8.1 China Point of Care Molecular Diagnostics Market
8.1.1 China Point of Care Molecular Diagnostics Market by Product & Service
8.1.2 China Point of Care Molecular Diagnostics Market by End User
8.1.3 China Point of Care Molecular Diagnostics Market by Technology
8.1.4 China Point of Care Molecular Diagnostics Market by Application
8.2 Japan Point of Care Molecular Diagnostics Market
8.2.1 Japan Point of Care Molecular Diagnostics Market by Product & Service
8.2.2 Japan Point of Care Molecular Diagnostics Market by End User
8.2.3 Japan Point of Care Molecular Diagnostics Market by Technology
8.2.4 Japan Point of Care Molecular Diagnostics Market by Application
8.3 India Point of Care Molecular Diagnostics Market
8.3.1 India Point of Care Molecular Diagnostics Market by Product & Service
8.3.2 India Point of Care Molecular Diagnostics Market by End User
8.3.3 India Point of Care Molecular Diagnostics Market by Technology
8.3.4 India Point of Care Molecular Diagnostics Market by Application
8.4 South Korea Point of Care Molecular Diagnostics Market
8.4.1 South Korea Point of Care Molecular Diagnostics Market by Product & Service
8.4.2 South Korea Point of Care Molecular Diagnostics Market by End User
8.4.3 South Korea Point of Care Molecular Diagnostics Market by Technology
8.4.4 South Korea Point of Care Molecular Diagnostics Market by Application
8.5 Singapore Point of Care Molecular Diagnostics Market
8.5.1 Singapore Point of Care Molecular Diagnostics Market by Product & Service
8.5.2 Singapore Point of Care Molecular Diagnostics Market by End User
8.5.3 Singapore Point of Care Molecular Diagnostics Market by Technology
8.5.4 Singapore Point of Care Molecular Diagnostics Market by Application
8.6 Malaysia Point of Care Molecular Diagnostics Market
8.6.1 Malaysia Point of Care Molecular Diagnostics Market by Product & Service
8.6.2 Malaysia Point of Care Molecular Diagnostics Market by End User
8.6.3 Malaysia Point of Care Molecular Diagnostics Market by Technology
8.6.4 Malaysia Point of Care Molecular Diagnostics Market by Application
8.7 Rest of Asia Pacific Point of Care Molecular Diagnostics Market
8.7.1 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
8.7.2 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User
8.7.3 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology
8.7.4 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview
TABLE 1 Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Point of Care Molecular Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Point of Care Molecular Diagnostics Market
TABLE 5 Acquisition and Mergers– Point of Care Molecular Diagnostics Market
TABLE 6 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 7 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 8 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 9 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 10 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 11 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 12 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 13 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 14 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 15 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 16 Asia Pacific Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 17 Asia Pacific Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 18 Asia Pacific Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 19 Asia Pacific Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 20 Asia Pacific Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 21 Asia Pacific Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 24 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 25 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 26 Asia Pacific RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 27 Asia Pacific RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 28 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 29 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 31 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 32 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 33 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 34 Asia Pacific Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 35 Asia Pacific Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 36 Asia Pacific Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 37 Asia Pacific Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 38 Asia Pacific Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 39 Asia Pacific Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 40 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
TABLE 41 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
TABLE 42 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 43 Asia Pacific Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 44 Asia Pacific Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 45 Asia Pacific Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 46 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 47 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 48 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 49 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 50 China Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 51 China Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 52 China Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 53 China Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 54 China Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 55 China Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 56 China Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 57 China Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 58 China Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 59 China Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 60 Japan Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 61 Japan Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 62 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 63 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 64 Japan Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 65 Japan Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 66 Japan Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 67 Japan Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 68 Japan Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 69 Japan Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 70 India Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 71 India Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 72 India Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 73 India Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 74 India Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 75 India Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 76 India Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 77 India Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 78 India Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 79 India Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 80 South Korea Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 81 South Korea Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 82 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 83 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 84 South Korea Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 85 South Korea Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 86 South Korea Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 87 South Korea Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 88 South Korea Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 89 South Korea Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 90 Singapore Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 91 Singapore Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 92 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 93 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 94 Singapore Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 95 Singapore Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 96 Singapore Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 97 Singapore Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 98 Singapore Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 99 Singapore Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 100 Malaysia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 101 Malaysia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 102 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 103 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 104 Malaysia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 105 Malaysia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 106 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 107 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 108 Malaysia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 109 Malaysia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 110 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 111 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 112 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 113 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 114 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 115 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 116 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 117 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 118 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 119 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 120 Key Information – Abbott Laboratories
TABLE 121 Key Information – Bayer AG
TABLE 122 Key Information – Thermo Fisher Scientific, Inc.
TABLE 123 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 124 Key information – BioMerieux S.A.
TABLE 125 Key Information – Qiagen N.V.
TABLE 126 Key Information – Danaher Corporation
TABLE 127 Key Information – Bio-Rad Laboratories, Inc.
TABLE 128 key Information – Agilent Technologies, Inc.
TABLE 129 key information – Nova Biomedical Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Asia Pacific Point of Care Molecular Diagnostics Market share by Product & Service, 2022
FIG 5 Asia Pacific Point of Care Molecular Diagnostics Market share by Product & Service, 2030
FIG 6 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
FIG 7 Asia Pacific Point of Care Molecular Diagnostics Market share by End User, 2022
FIG 8 Asia Pacific Point of Care Molecular Diagnostics Market share by End User, 2030
FIG 9 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 10 Asia Pacific Point of Care Molecular Diagnostics Market share by Technology, 2022
FIG 11 Asia Pacific Point of Care Molecular Diagnostics Market share by Technology, 2030
FIG 12 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
FIG 13 Asia Pacific Point of Care Molecular Diagnostics Market share by Application, 2022
FIG 14 Asia Pacific Point of Care Molecular Diagnostics Market share by Application, 2030
FIG 15 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
FIG 16 Asia Pacific Point of Care Molecular Diagnostics Market share by Country, 2022
FIG 17 Asia Pacific Point of Care Molecular Diagnostics Market share by Country, 2030
FIG 18 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 19 Swot Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.

Purchase Full Report of
Asia Pacific Point of Care Molecular Diagnostics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL